Source comparison
Side-by-Side Comparison
Class — FDA Status Research Use Primary Uses neurotrophic signaling, nootropic signaling neuroimmune modulation Administration subcutaneous injection or intranasal Typical Dosing 250–500 mcg/day subcutaneous or intranasal Evidence Level Preclinical / Research
This comparison does not assign a generated winner or score.
- Class
- —
- FDA Status
- Research Use
- Primary Uses
- neurotrophic signaling, nootropic signaling
- neuroimmune modulation
- Administration
- subcutaneous injection or intranasal
- Typical Dosing
- 250–500 mcg/day subcutaneous or intranasal
- Evidence Level
- Preclinical / Research
- Common Side Effects